Natural history of HIV-1 infection
- PMID: 11144640
- DOI: 10.1016/s0891-5520(05)70135-5
Natural history of HIV-1 infection
Abstract
Infection with the human immunodeficiency virus type 1 (HIV-1) results in progressive loss of immune function marked by depletion of the CD4+ T-lymphocytes, leading to opportunistic infections and malignancies characteristic of AIDS. Although both host and viral determinants influence the rate of disease progression, the median time from initial infection to the development of AIDS among untreated patients ranges from 8 to 10 years. The clinical staging of HIV disease and the relative risk of developing opportunistic infections historically relied on the CD4+ T-lymphocyte counts. Although more recent studies have shown the importance of viral load quantitation in determining the rate of disease progression, it is still useful to categorize HIV disease stage on the basis of the degree of immunodeficiency: early disease (CD4+ > 500 cells/mL), mid-stage disease (CD4+ between 200 and 500 cells/mL), and end-stage disease (CD4+ < 50 cell/mL). This article reviews the natural history of HIV disease at each stage of HIV-1 infection with emphasis on acute infection and the major virologic and immunologic determinants of disease progression.
Similar articles
-
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.J Infect Dis. 2004 May 15;189(10):1793-801. doi: 10.1086/386306. Epub 2004 Apr 26. J Infect Dis. 2004. PMID: 15122515
-
Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1175-9. doi: 10.1089/08892220260387913. AIDS Res Hum Retroviruses. 2002. PMID: 12487823
-
Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1099-105. doi: 10.1089/088922201316912709. AIDS Res Hum Retroviruses. 2001. PMID: 11522179 Clinical Trial.
-
The pathogenesis of HIV-1 infection.Br Med Bull. 2001;58:61-72. doi: 10.1093/bmb/58.1.61. Br Med Bull. 2001. PMID: 11714624 Review.
-
Markers and determinants of progression of HIV-1 infection.J Lab Clin Med. 1998 May;131(5):406-9. doi: 10.1016/s0022-2143(98)90140-8. J Lab Clin Med. 1998. PMID: 9605104 Review. No abstract available.
Cited by
-
CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm.Retrovirology. 2013 Feb 27;10:24. doi: 10.1186/1742-4690-10-24. Retrovirology. 2013. PMID: 23446039 Free PMC article.
-
A stochastic multi-scale model of HIV-1 transmission for decision-making: application to a MSM population.PLoS One. 2013 Nov 26;8(11):e70578. doi: 10.1371/journal.pone.0070578. eCollection 2013. PLoS One. 2013. PMID: 24302983 Free PMC article.
-
Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):181-95. doi: 10.1097/QAI.0000000000000271. J Acquir Immune Defic Syndr. 2014. PMID: 24977473 Free PMC article. Review.
-
Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.PLoS One. 2016 Dec 12;11(12):e0161920. doi: 10.1371/journal.pone.0161920. eCollection 2016. PLoS One. 2016. PMID: 27941971 Free PMC article.
-
Distinct chemokine triggers and in vivo migratory paths of fluorescein dye-labeled T Lymphocytes in acutely simian immunodeficiency virus SIVmac251-infected and uninfected macaques.J Virol. 2005 Nov;79(21):13759-68. doi: 10.1128/JVI.79.21.13759-13768.2005. J Virol. 2005. PMID: 16227295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials